| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/07/2009 | CA2352503C Il-5 inhibiting 6-azauracil derivatives |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/07/2009 | CA2174494C Benzofurans |
| 04/02/2009 | WO2009042907A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | WO2009041559A1 Indazole acrylic acid amide compound |
| 04/02/2009 | WO2009041521A1 Quinolone derivative |
| 04/02/2009 | WO2009040290A1 Quinoline derivatives as 5ht5a receptor antagonists |
| 04/02/2009 | WO2009019553A3 Imidazopyridinones |
| 04/02/2009 | WO2009019303A3 A process for the preparation or purification of olmesartan medoxomil |
| 04/02/2009 | US20090088466 Opioid receptor ligands |
| 04/02/2009 | US20090088456 2-Pyridinylethylcarboxamide derivatives and their use as Fugicides |
| 04/02/2009 | US20090088428 (R)-3-(3,5-Dichloro-4'-morpholin-4-yl-biphenyl-4-ylmethyl)-1-(4,5,6,7-tetrahydro-1H-benzoimidazol-5-yl)-pyrrolidin-2-one for treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome |
| 04/02/2009 | US20090088422 4-imidazolin-2-one compounds |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | DE19959619B4 Sterisch gehinderte Aminverbindungen und damit stabilisierte organische Materialien Sterically hindered amine compounds and organic materials stabilized therewith |
| 04/02/2009 | CA2700841A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | CA2700113A1 Indazole acrylic acid amide compound |
| 04/02/2009 | CA2700088A1 Quinolone derivative |
| 04/02/2009 | CA2699697A1 Quinoline derivatives as 5ht5a receptor antagonists |
| 04/01/2009 | EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists |
| 04/01/2009 | EP2042488A1 Matrix metalloproteinase inhibitors |
| 04/01/2009 | EP2042478A1 Method for producing -diaryl electron-withdrawing group substituted compound |
| 04/01/2009 | EP2042171A1 Therapeutic or prophylactic agent for allergic dermatitis |
| 04/01/2009 | EP2041158A2 Peptide epoxyketones for proteasome inhibition |
| 04/01/2009 | EP2041125A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds |
| 04/01/2009 | EP2041122A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and agents containing said compounds |
| 04/01/2009 | EP2041121A1 An enantioselective synthesis of pyrrolidine-substituted flavones |
| 04/01/2009 | EP2041119A1 Pyrazolylbenzimidazole derivatives, compositions containing them and use thereof |
| 04/01/2009 | EP2041113A1 Novel pyridazine derivatives |
| 04/01/2009 | EP2041086A1 Indole compounds |
| 04/01/2009 | EP2041085A1 Pyrrole derivatives and their methods of use |
| 04/01/2009 | EP2041069A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 04/01/2009 | EP1773770B1 Indole-2-carboxamidine derivatives as nmda receptor antagonists |
| 04/01/2009 | EP1653961A4 Inhibitors of akt activity |
| 04/01/2009 | EP1638960A4 Preparation of chemical compounds |
| 04/01/2009 | EP1620429B1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 04/01/2009 | EP1513530A4 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 04/01/2009 | EP1506175B1 N-substituted tricyclic 3-aminopyrazoles as pdgf receptor inhibitors |
| 04/01/2009 | EP1082308B1 Heterocyclically substituted amides used as calpain inhibitors |
| 04/01/2009 | CN101400677A Compounds |
| 04/01/2009 | CN101400674A Antibiotic compounds |
| 04/01/2009 | CN101400654A 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors |
| 04/01/2009 | CN101397313A Maillard reaction intermediate, preparation method and use thereof |
| 04/01/2009 | CN101397296A Levalfuzosin, preparation method and use thereof |
| 04/01/2009 | CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products |
| 04/01/2009 | CN100473647C Pyridazinones and triazinones and medicinal use thereof |
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/31/2009 | US7511148 Process for preparing thiazolidinediones |
| 03/31/2009 | US7511145 Bicyclic heteroaryl derivatives |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511069 Indazole compounds as β3 andrenoceptor agonist |
| 03/31/2009 | US7511066 Antithrombotic aromatic ethers |
| 03/31/2009 | US7511062 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors |
| 03/31/2009 | US7511061 Triazoles as farnesyl transferase inhibitors |
| 03/31/2009 | US7511044 Vanilloid receptor ligands and their use in treatments |
| 03/31/2009 | US7511042 1-[5-(5-tert-Butyl-2-methoxy-3-methylsulfamoyl-phenylcarbamoyl)-2-methyl-phenyl]-1H-1,2,3-triazole-4-carboxylic acid (2,2-dimethyl-propyl)-amide; small molecule cytokine inhibitor; optimized efficacy, pharmacokinetic; antiinflammatory agent, osteoarthritis, asthma, gastrointestinal, respiratory disorder |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/31/2009 | CA2417897C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 03/26/2009 | WO2009039135A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 03/26/2009 | WO2009039134A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | WO2009038784A1 Triazole fused heteroaryl compounds as p38 kinase inhibitors |
| 03/26/2009 | WO2009038157A1 2,3-dihydroiminoisoindole derivative |
| 03/26/2009 | WO2009037247A1 Pyrazine derivatives and their use as potassium channel modulators |
| 03/26/2009 | WO2009037244A2 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 03/26/2009 | WO2009036938A1 Substituted nicotinamide compounds and the use thereof in pharmaceutical products |
| 03/26/2009 | WO2009016560A3 Trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 03/26/2009 | WO2009016253A3 Cyanomethyl substituted n-acyl tryptamines |
| 03/26/2009 | WO2008139288A3 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
| 03/26/2009 | US20090082567 2,4-pyrimidinediamine compounds and their uses |
| 03/26/2009 | US20090082414 Deuterium-enriched viramidine |
| 03/26/2009 | US20090082392 Substituted Carboxylic Acids |
| 03/26/2009 | US20090082377 Matrix Metalloproteinase Inhibitors |
| 03/26/2009 | US20090082362 Use of capsaicin receptor antagonists to treat symptoms of tear gas exposure |
| 03/26/2009 | US20090082359 5-pyridinone substituted indazoles |
| 03/26/2009 | US20090081165 Bicyclic heteroaryl derivatives |
| 03/26/2009 | CA2699989A1 N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor |
| 03/26/2009 | CA2699986A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | CA2699689A1 Substituted nicotinamide compounds and their use in medicaments |
| 03/26/2009 | CA2698527A1 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists |
| 03/25/2009 | EP2039687A1 Therapeutic or prophylactic agent for multiple sclerosis |
| 03/25/2009 | EP2039685A2 Heterobicyclic compounds as P38 inhibitors |
| 03/25/2009 | EP2039683A2 Vasculostatic agents and methods of use thereof |
| 03/25/2009 | EP2038276A1 Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
| 03/25/2009 | EP2038264A1 Tetrazole-substituted arylamides |
| 03/25/2009 | EP2038262A2 Triazole compounds that modulate hsp90 activity |
| 03/25/2009 | EP2038261A2 Pyrazine derivatives with extended conjugation and uses thereof |
| 03/25/2009 | EP2037741A1 Compositions and methods relating to novel compounds and targets thereof |
| 03/25/2009 | EP2037739A2 Benzyl-substituted quinolone m1 receptor positive allosteric modulators |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1696931B1 Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 03/25/2009 | EP1592680B9 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors |
| 03/25/2009 | EP1472228B1 Process for the manufacture of hmg-coa reductase inhibitors |
| 03/25/2009 | EP1357113B1 6-(1-fluoroethyl)-5-iodo-4-aminopyrimidine compounds, process for preparation of the same, and pest controllers for agricultural and horticultural use |
| 03/25/2009 | CN101395152A Sigma receptor compounds |
| 03/25/2009 | CN101395151A Novel method for the preparation of stavudine polymorphic form I and form II |
| 03/25/2009 | CN101395136A New pyridin-3-amine derivatives |
| 03/25/2009 | CN101391995A Water-soluble paclitaxel ester compounds containing 1,2,3-triazole and preparation method |
| 03/25/2009 | CN101391994A Synthetic method of itraconazole key intermediate triazole compounds |
| 03/25/2009 | CN100472333C Organophotoreceptor with a charge transport material having two epoxidated-carbazolyl groups |